53 related articles for article (PubMed ID: 32052051)
1. Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.
Li S; Hoefnagel SJM; Krishnadath KK
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001670
[TBL] [Abstract][Full Text] [Related]
2. Unmet needs in Barret's esophagus diagnosis and treatment: a narrative review.
Friedel D
Transl Gastroenterol Hepatol; 2023; 8():30. PubMed ID: 37601742
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease.
Dos Santos Cunha AC; Simon AG; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6917-6929. PubMed ID: 36826594
[TBL] [Abstract][Full Text] [Related]
4. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
Sostres C; Lacarta P; Lanas A
Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
Kamboj AK; Katzka DA; Iyer PG
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
[TBL] [Abstract][Full Text] [Related]
6. Is the age of diagnosis of esophageal adenocarcinoma getting younger? Analysis at a tertiary care center.
Strauss A; Min EJ; Long Q; Gabriel P; Yang YX; Falk GW
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32052051
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
8. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.
Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR
Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
11. A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer.
Dwyer AJ; Murphy CC; Boland CR; Garcia R; Hampel H; Limburg P; Lowery J; Zauber AG; Waring S; Worrall S; Perea J; Siegel R; Lee J; Molmenti C; Sears CL; Buckhaults P; Hayes R; Hussan H; de Miranda N; Palles C; Diaz L; Song M; Cercek A; Lieu CH; Patel SG; Karlitz JJ; Cao Y; Demb J; Blatchford P; Risendal B; Staples ES; Wali A; Daschner P; Loomans-Kropp H; Flores R; Levell CL; Wehling K; Martin J; Pesmen C; Kuchar V; Soisson R; Davis A; Ahnen D
Gastroenterology; 2019 Aug; 157(2):280-288. PubMed ID: 31095950
[No Abstract] [Full Text] [Related]
12. Cancer statistics, 2019.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2019 Jan; 69(1):7-34. PubMed ID: 30620402
[TBL] [Abstract][Full Text] [Related]
13. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
[TBL] [Abstract][Full Text] [Related]
14. Esophageal cancer in patients under 50: a SEER analysis.
Zeng Y; Ruan W; Liu J; Liang W; He J; Cui F; Pan H; He J
J Thorac Dis; 2018 May; 10(5):2542-2550. PubMed ID: 29997914
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
